We are live on ! Find out more
OM icon

Outset Medical
OM

149 hedge funds and large institutions have $721M invested in Outset Medical in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more call options, than puts

Call options by funds: $9.57M | Put options by funds: $2.15M

71% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 34

0.45% less ownership

Funds ownership: 7.21% → 6.76% (-0.45%)

3% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 35

2% less funds holding

Funds holding: 152 → 149 (-3)

69% less capital invested

Capital invested by funds: $2.33B → $721M (-$1.61B)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
149
Holders Change
-3
Holders Change %
-1.97%
% of All Funds
2.51%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
34
Increased
58
Reduced
34
Closed
35
Calls
$9.57M
Puts
$2.15M
Net Calls
+$7.42M
Net Calls Change
+$159K

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$61.4M
2
CWG
C WorldWide Group
Denmark
+$21.5M
3
EHI
Eagle Health Investments
Connecticut
+$19.8M
4
Barclays
Barclays
United Kingdom
+$17M
5
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$15M

Top Sellers

1
PHS
PFM Health Sciences
California
-$128M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$89.5M
3
PA
Perceptive Advisors
New York
-$25.4M
4
BlackRock
BlackRock
New York
-$25.3M
5
Allspring Global Investments
Allspring Global Investments
North Carolina
-$15.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$6.15M +$3.88M +9,026 +49%
DM
27
Deerfield Management
New York
$5.95M – – –
Fidelity International
28
Fidelity International
Bermuda
$5.28M -$14.5M -33,681 -59%
Goldman Sachs
29
Goldman Sachs
New York
$5.19M +$4.8M +11,152 +92%
Charles Schwab
30
Charles Schwab
California
$4.59M -$57.6K -134 -0.6%
NCGI
31
Next Century Growth Investors
Minnesota
$3.82M +$7.38M +17,148 New
WP
32
Woodline Partners
California
$3.62M -$1.91M -4,429 -21%
Deutsche Bank
33
Deutsche Bank
Germany
$3.56M +$3.63M +8,448 +113%
Bank of America
34
Bank of America
North Carolina
$2.87M -$794K -1,846 -13%
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$2.72M -$1.29K -3 -0%
RPAM
36
Rhenman & Partners Asset Management
Sweden
$2.67M +$5.16M +12,000 New
Ameriprise
37
Ameriprise
Minnesota
$2.66M +$1.67M +3,874 +48%
Walleye Capital
38
Walleye Capital
New York
$2.65M +$2.07M +4,803 +68%
Marshall Wace
39
Marshall Wace
United Kingdom
$2.55M +$4.91M +11,418 New
CSS
40
Cubist Systematic Strategies
Connecticut
$2.31M +$3.76M +8,731 +540%
Neuberger Berman Group
41
Neuberger Berman Group
New York
$2.14M +$146K +339 +4%
Two Sigma Investments
42
Two Sigma Investments
New York
$2.06M +$3.97M +9,229 New
N
43
Nuveen
North Carolina
$2.02M +$51.2K +119 +1%
CS
44
Candriam SCA
Luxembourg
$1.76M – – –
GCM
45
Graham Capital Management
Connecticut
$1.74M +$3.35M +7,795 New
SEI Investments
46
SEI Investments
Pennsylvania
$1.6M +$2M +4,647 +183%
ACM
47
Altium Capital Management
New York
$1.54M +$1.49M +3,458 +100%
UBS Group
48
UBS Group
Switzerland
$1.47M +$2.79M +6,475 +6,475%
Assenagon Asset Management
49
Assenagon Asset Management
Luxembourg
$1.47M +$2.68M +6,240 +1,863%
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.41M – – –
1
2
3 4 5

OM Hedge Fund Activity: Q2 2022 in Review

149 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q2 2022, worth a combined $721M — down 69% from $2.33B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of OM and 34 opened new positions — a net loss of 1 holder — while 34 trimmed existing stakes and 58 added.

The largest buyer was JP Morgan Chase, adding an estimated $61.4M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $128M sold.

  • 149 institutional investors held Outset Medical (OM) as of Q2 2022, down from 152 in Q1 2022.
  • Funds reported $721M of Outset Medical stock for Q2 2022, down 69% quarter-over-quarter.
  • 34 funds opened new Outset Medical positions in Q2 2022 and 35 closed out, a net change of -1 holder.
  • The largest Outset Medical buyer in Q2 2022 was JP Morgan Chase, an estimated $61.4M added.
  • The largest Outset Medical seller in Q2 2022 was PFM Health Sciences, an estimated $128M sold.

Based on aggregated 13F filings for Q2 2022.